Since the earliest days of the non-invasive technique of in vivo near infra-red spectroscopy (ivNIRS) there has been the potential to monitor the redox state of the important respiratory chain enzyme cytochrome aa3. This has particular relevance to hypoxic-ischaemic insults to brain cells, such as may occur in the fetus during birth, in newborns with unstable cerebral autoregulation, or in adults with many forms of brain injury. However, although the feasibility of monitoring cytaa3 with ivNIRS has been largely proven there is currently no apparent interest in applying the method clinically. This might be a matter of a lack of knowledge in how to use the data collected, or it might well be that equipment is too expensive, or cumbersome or unreliable. Do any clinicians have a view on the clinical value of this method? Do any engineers feel that more needs to be done in refining the technology?